NASDAQ:META - Nasdaq - US30303M1027 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to META. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-04-17 | Truist Securities | Maintains | Buy -> Buy |
2025-04-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
2025-04-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
2025-04-15 | Wedbush | Maintains | Outperform -> Outperform |
2025-04-14 | DA Davidson | Maintains | Buy -> Buy |
2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
2025-04-14 | Citigroup | Maintains | Buy -> Buy |
2025-04-11 | UBS | Maintains | Buy -> Buy |
2025-04-10 | Piper Sandler | Maintains | Overweight -> Overweight |
2025-04-09 | Keybanc | Maintains | Overweight -> Overweight |
2025-04-09 | B of A Securities | Maintains | Buy -> Buy |
2025-04-08 | Guggenheim | Maintains | Buy -> Buy |
2025-04-08 | JP Morgan | Maintains | Overweight -> Overweight |
2025-04-07 | Jefferies | Maintains | Buy -> Buy |
2025-04-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
2025-03-31 | Jefferies | Maintains | Buy -> Buy |
2025-03-28 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
2025-03-18 | Keybanc | Maintains | Overweight -> Overweight |
2025-02-11 | Tigress Financial | Maintains | Strong Buy -> Strong Buy |
2025-01-30 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
2025-01-30 | Pivotal Research | Maintains | Buy -> Buy |
2025-01-30 | Mizuho | Maintains | Outperform -> Outperform |
2025-01-30 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
2025-01-30 | DA Davidson | Maintains | Buy -> Buy |
2025-01-30 | BMO Capital | Maintains | Market Perform -> Market Perform |
2025-01-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
2025-01-30 | UBS | Maintains | Buy -> Buy |
2025-01-30 | Needham | Reiterate | Underperform -> Underperform |
2025-01-30 | Keybanc | Reiterate | Overweight -> Overweight |
2025-01-30 | Oppenheimer | Maintains | Outperform -> Outperform |